CELC
Celcuity LLC
NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY
$87.64
+5.26% today
Updated 2026-07-30
Market cap
$5.26B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.90
Dividend yield
—
52W range
$13 – $151
Volume
1.7M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+5/9
Piotroski F-Score
Moderate
-1.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$160.64
+83.30%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Altman Z -1.23 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-55.31M
- Debt/equity 3.65x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $154000.00 | $0.00 |
| Net income | $-40.37M | $-63.78M | $-111.78M | $-177.04M | $-52.84M |
| EPS | — | — | — | — | $-3.90 |
| Free cash flow | $-36.17M | $-53.91M | $-83.72M | $-153.53M | $-55.31M |
| Profit margin | — | — | — | -114,962.34% | — |
Peer comparison
Smart narrative
Celcuity LLC trades at $87.64. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -1.23, it sits in the distress.
Frequently asked questions
What is Celcuity LLC's stock price?
Celcuity LLC (CELC) trades at $87.64.
Is Celcuity LLC overvalued?
Celcuity LLC carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Celcuity LLC (CELC)?
The 12-month analyst consensus target is $160.64, about 83.3% above the current $87.64. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Celcuity LLC's Altman Z-Score is -1.23, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-275.20%
Beta0.16
50D MA$113.88
200D MA$99.28
Shares out0.05B
Float0.03B
Short ratio—
Avg volume1.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—